you are here: HomeNewsIndia

COVID-19 Vaccine Tracker News: 5,615 beneficiaries receive coronavirus vaccine in India on January 26

More than 20.29 lakh people have so far been vaccinated for COVID-19 in India. Of these, 5,615 people received the vaccine on January 26.

January 27, 2021 / 08:34 AM IST
Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (COVID-19) pandemic, in Koraput. (Image: Reuters)

Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (COVID-19) pandemic, in Koraput. (Image: Reuters)

A total of 20,29,424 beneficiaries have so far been vaccinated for COVID-19 through 36,572 sessions held till the evening of January 26, the eleventh day of the immunisation drive, according to a provisional report of the Union Health Ministry.

On January 26, 5,615 beneficiaries were vaccinated in five states -- Andhra Pradesh (9), Karnataka (429), Rajasthan (216), Tamil Nadu (4926), and Telangana (35) -- till 7.00 pm through 194 vaccination sessions, the ministry said.

In view of Republic Day, a limited number of sessions in a limited number of states were conducted on January 26, said the ministry.

According to the Health Ministry data, the highest number of vaccinations in the country till now have been carried out in Karnataka at 2,31,601 followed by Odisha at 1,77,090, Rajasthan at 1,61,332, and Maharashtra at 1,36,901.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Prime Minister Narendra Modi launched the vaccination drive with healthcare workers at the frontline of India's COVID-19 battle getting their first jabs on January 16.

India’s drug regulator has approved two vaccines - Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India (SII) - for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.

Here are all developments related to the COVID-19 vaccine in India:

> A 27-year-old healthcare worker died in Odisha on January 26, three days after taking the COVID-19 vaccine, while the state health department said his death is not related to vaccination. The man who was inoculated on January 23 died in Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR) at Burla in Sambalpur district, an official statement said.

> Sri Lanka has expressed appreciation and gratitude to India for sending 5,00,000 doses of coronavirus vaccine to the island country. Prime Minister Mahinda Rajapaksa told the Cabinet that the Indian High Commissioner in Colombo informed that India would be sending 5,00,000 vaccines to Sri Lanka and they will arrive there on January 28.

> Over 7,400 healthcare workers received COVID-19 vaccine shots in Delhi on Monday as the inoculation drive picked up pace in the city, recording 91 percent turnout for the day, officials said.

> South African president Cyril Ramaphosa accused rich countries of hoarding coronavirus vaccines. The rich countries of the world went out and acquired large doses of vaccines from developers and manufacturers, and some countries have even gone beyond and acquired four times what their population needs, he said.

> Moderna Inc said it believes its COVID-19 vaccine protects against new variants found in Britain and South Africa, although it will test a new booster shot aimed at the South African variant after concluding the antibody response could be diminished. The company said in a news release it found no reduction in the antibody response against the variant found in Britain. Against the South African variant, it found a reduced response but still believed its two-dose regimen would provide protection.

Here is the state-wise vaccination:
StatesTotal Beneficiaries
A & N Islands2,369
Andhra Pradesh1,56,129
Madhya Pradesh67,083
Tamil Nadu73,953
West Bengal1,22,851

(With inputs from PTI)

Follow our full coverage on COVID-19 here.
Moneycontrol News
first published: Jan 27, 2021 08:03 am

stay updated

Get Daily News on your Browser